Pfizer: oncology franchise growth; Start with 'Buy' (NYSE:PFE)

This article was written by

More than 15 years of professional experience in global equity investment across all sectors. My investment style is fundamental, ascending, long-term and oriented to quality growth. I look for companies specialized in niche markets, with strong growth potential, a solid management team, a solid capital allocation policy and, most importantly, a reasonable valuation. I don't chase quarterly results or follow the herd mentality. I don't use short-term stock performance as a measure of a company's quality. My goal is to achieve a 15% annual return on my portfolio. I typically build my portfolio with 15 to 20 stocks, focusing on diversification of holdings, risk management, macro-driven sector weightings, and disciplined trading and valuations as key factors. Disclosure: Lighting Rock and I are working on the same investment team. I'm writing here independently.

Analyst Disclosure: I/we do not have any stock, options or similar derivative positions in any of the companies mentioned, and we have no plans to initiate such positions within the next 72 hours. I wrote this article myself and it expresses my own opinions. I don't receive any compensation for it (aside from Seeking Alpha). I have no business relationship with any company whose shares are mentioned in this article.

Seeking Alpha Disclosure: Past performance is no guarantee of future results. No recommendations or advice are given as to whether an investment is suitable for a particular investor. The views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a securities broker, broker, investment advisor or investment bank licensed in the US. Our analysts are third-party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or body. regulator.

Source link

Leave a Comment